Eye Inflammation
DUREZOL® (difluprednate ophthalmic emulsion) 0.05% is a corticosteroid used for the treatment of inflammation and pain associated with eye surgery.
Patients should be advised not to wear contact lenses when using DUREZOL® Emulsion. Do not allow the dropper tip to touch any surface as this may contaminate the emulsion.
DUREZOL® Emulsion is not to be used in active viral diseases of the cornea and conjunctiva and also in bacterial or fungal infections of the eye. Ophthalmic side effects may include glaucoma, cataracts, and infections. DUREZOL® Emulsion should be used during pregnancy only if the potential benefit justifies the potential risk to the embryo or fetus. Safety and efficacy in pediatric patients has not been established.
For full prescribing informtion, see the below product insert.
U.S. Product Insert
DUREZOL® Emulsion [PDF]
NEVANAC® Ophthalmic Suspension
NEVANAC® (nepafenac ophthalmic suspension) 0.1% treats eye pain and inflammation resulting from cataract surgery.
Do not wear contact lenses while using NEVANAC® suspension. Patients should not touch the bottle tip to any surface to avoid the risk of contamination.
This product should not be taken by patients with a sensitivity or allergy to its ingredients. Safety and efficacy have not been determined in children under age 10. Caution should be used when administering this drug to pregnant or nursing women. This drug should not be used in late pregnancy. The most common side effects of NEVANAC® suspension include decreased visual acuity, a feeling that something is in the eye, increased eye pressure or a sticky sensation, as well as other effects. If you experience any of these symptoms contact your doctor. As with all NSAIDs, this drug may delay ocular healing and prolonged use may result in corneal problems. For full U.S. prescribing information, see the product insert below.
U.S. Product Insert
NEVANAC® Ophthalmic Suspension [PDF]
TRIESENCE® Ophthalmic Suspension
TRIESENCE® (triamcinoline acetonaide injectable suspension) 40 mg/ml is a preservative-free injectable suspension designed and approved for intraocular use in the United States, for treatment of uveitis, certain types of eye inflammation unresponsive to topical corticosteroids, sympathetic ophthalmia, and temporal arteritis. The drug is also approved for use in assisting with visualization of the retina during surgery. For more information on surgical indications, see surgical products.
TRIESENCE® suspension is contraindicated in patients with systemic fungal infection and those with hypersensitivity to triamcinolone or any component of this product. Ophthalmic side effects may include cataracts, infections, and glaucoma.
U.S. Product Insert
TRIESENCE® Ophthalmic Suspension [PDF]
TOBRADEX® Ophthalmic Suspension
TOBRADEX® (tobramycin and dexamethasone) sterile ophthalmic suspension and ointment have been the most frequently prescribed anti-infective and anti-inflammatory combination drug on the market for 20 years. TOBRADEX® suspension is used to treat eye inflammation where infection or the risk of infection is present.
Do not wear contact lenses while using TOBRADEX® suspension. Patients should not touch the bottle tip to any surface to avoid the risk of contamination.
This product should not be taken by patients with a sensitivity or allergy to its ingredients or by persons with viral or fungal infections of the eye. Safety and efficacy have not been determined in children under age two. Caution should be used when administering this drug to pregnant or nursing women. The most common side effects of TOBRADEX® suspension are lid itching and swelling, but patients may also experience elevated intraocular pressure (IOP) and delayed wound healing, as well as other effects. If you experience any of these symptoms contact your doctor. Prolonged use of this drug may result in a higher likelihood of fungal infection or secondary bacterial infection. For full U.S. prescribing information, see the product insert below.
U.S. Product Insert
TOBRADEX® Ophthalmic Suspension [PDF]
